Compare Supplements

Investigational — NO approved dose. Phase-2 trials used once-weekly subcutaneous injection with stepwise escalation up to 4.8-6.0 mg maintenance. There is no approved regimen; do not self-dose an unapproved drug.

Any time

Once-weekly subcutaneous injection (investigational only)

30grams

Any time · with food (preferred)

Whey Protein Isolate

• Not a dietary supplement and not an approved drug — investigational; do not self-source grey-market vials
• Personal/family history of medullary thyroid carcinoma or MEN 2 (expected GLP-1-class thyroid C-cell warning)
• History of pancreatitis

• Oral medications (delayed gastric emptying)
• Insulin / insulin secretagogues (sulfonylureas)
• Other GLP-1 / incretin drugs

• Milk allergy (use plant-based alternatives)
• Severe lactose intolerance (use isolate or lactose-free)

• Levodopa
• Levothyroxine
• Alendronate (bisphosphonates)